Daniel K. Reef

Internal Medicine

101 Manning Dr # R
Chapel Hill, NC 27514

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Ibrutinib plus venetoclax for patients with relapsed or refractory mantle cell lymphoma: an editorial on the phase 3 SYMPATICO trial.

Ibrutinib plus venetoclax for patients with relapsed or refractory mantle cell lymphoma: an editorial on the phase 3 SYMPATICO trial.

Journal: AME clinical trials review

Published: June 22, 2026

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

Journal: Blood cancer journal

Published: March 06, 2026

Cellular and Novel Immunotherapies for Classic Hodgkin Lymphoma.

Cellular and Novel Immunotherapies for Classic Hodgkin Lymphoma.

Journal: Hematology/oncology clinics of North America

Published: February 10, 2026

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.

Journal: HemaSphere

Published: November 21, 2025

Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort Study.

Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort Study.

Journal: Blood advances

Published: November 17, 2025

Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

Journal: Blood advances

Published: November 17, 2025

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.

Journal: Clinical hematology international

Published: October 08, 2022

Defining POMC neurons using transgenic reagents: impact of transient Pomc expression in diverse immature neuronal populations.

Defining POMC neurons using transgenic reagents: impact of transient Pomc expression in diverse immature neuronal populations.

Journal: Endocrinology

Published: December 15, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026